UNSPSC 51402502: Gedocarnil

This classification denotes an anxiolytic with the molecular formula C23H21ClN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BWP53NPW3F, chemically known as isopropyl 5-(p-chlorophenoxy)-4-(methoxymethyl)-9h-pyrido(3,4-b)indole-3-carboxylate. but generally known as gedocarnil, which bears US NIH Compound Identifier 219095. European Medicines Agency schedules Gedocarnil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07888MIG. The term GEDOCARNIL is an International Non-Proprietary Name.

UNSPSC 51402502 Gedocarnil, a Commodity code, does not map to state and local procurement activity in the recent opportunities provided. The code nominally describes a pharmaceutical compound, but the three recent state and local solicitations tagged under it pursue naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, and multi-source generic pharmaceuticals and OTC products — none of which involve gedocarnil as a procured item. The mismatch suggests either a classification error in the opportunities or that gedocarnil itself sees no recent state and local contracting activity.

The three solicitations point instead to broader pharmaceutical procurement by health departments, state HHS commissions, and cooperative purchasing alliances. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023, a date in the past) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas Health and Human Services Commission issued an RFI on April 3, 2026 to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, released an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon. The code shows no relevant current activity and warrants clarification before allocation of business development resources.